journal article·2025-10Open access

Melt electrowritten medium chain length polyhydroxyalkanoate cardiac patches for Post-MI cardiac regeneration

Qasim A. Majid, Pragati Pandey, Mohamed Bellahcene, Christopher L. Grigsby, Molly M. Stevens, Virpi Talman, Daniel J. Stuckey, Sian E. Harding, Ipsita Roy, Gábor Földes

Abstract

Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) hold promise in averting the development of heart failure with reduced ejection fraction (HFrEF) following myocardial infarction (MI) by potentially regenerating the infarcted myocardium and restoring left ventricular contractility. However, challenges remain regarding the structural and functional maturation states of these cells, as well as their retention and integration into the myocardium. Here, we developed a novel three-dimensional cardiac patch and evaluated its potential to instigate cardiac regeneration. For the first time, melt electrowriting (MEW) was utilised to fabricate reproducible, structurally anisotropic, and handleable scaffolds from high molecular weight, medium chain-length polyhydroxyalkanoates (MCL-PHAs). These MEW-PHA scaffolds maintained hPSC-CMs, facilitating their rapid structural maturation and functional improvement in vitro. Different combinations of hPSC-derived cardiovascular cells were seeded onto the MEW-PHA scaffolds and stacked to create synchronously beating, multi-scaffold cardiac patches. These were well-accepted in a murine MI model without capsule formation. Notably, cardiac patches containing hPSC-derived cardiac microvascular-like endothelial cells (hPSC-CMVECs) initiated vascular regeneration within the infarcted myocardium. This novel advancement enabled the reproducible fabrication of high molecular weight MCL-PHA-based MEW cardiac patches that matured hPSC-CMs and promoted vascular regeneration, offering potential for future improvement in post-MI cardiac function through enhanced hPSC-CM retention.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine · Cardiac Structural Anomalies and Repair

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (88)

Show source-provided references
1. Dynamics of cell generation and turnover in the human heart10.1016/j.cell.2015.05.026 ↗
2. Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials10.1016/j.jacc.2016.01.069 ↗
3. AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines
4. Do patients have worse outcomes in heart failure than in cancer? A primary care-based cohort study with 10-year follow-up in Scotland10.1002/ejhf.822 ↗
5. Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatment10.1002/ejhf.1632 ↗
6. Long-term follow-up of survival after passive containment surgery in dilated cardiomyopathy10.1016/j.amsu.2022.104241 ↗
7. Magnetic resonance imaging evaluation of remodeling by cardiac elastomeric tissue scaffold biomaterials in a rat model of myocardial infarction10.1089/ten.tea.2010.0213 ↗
8. Lack of remuscularization following transplantation of human embryonic stem cell-derived cardiovascular progenitor cells in infarcted nonhuman Primates10.1161/CIRCRESAHA.117.311578 ↗
9. Natural biomaterials for cardiac tissue engineering: a highly biocompatible solution10.3389/fcvm.2020.554597 ↗
10. Optimizing blended collagen-fibrin hydrogels for cardiac tissue engineering with human iPSC-derived cardiomyocytes10.1021/acsbiomaterials.8b01112 ↗
11. Measuring age-dependent myocardial stiffness across the cardiac cycle using MR elastography: a reproducibility study10.1002/mrm.25760 ↗
12. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance10.1152/ajpheart.01017.2005 ↗
13. Medium chain length polyhydroxyalkanoates, promising new biomedical materials for the future10.1016/j.mser.2010.11.002 ↗
14. The topographical effect of electrospun nanofibrous scaffolds on the in vivo and in vitro foreign body reaction10.1002/jbm.a.32609 ↗
15. Biosynthesis and characterization of a novel, biocompatible medium chain length polyhydroxyalkanoate by Pseudomonas mendocina CH50 using coconut oil as the carbon source10.1007/s10856-018-6183-9 ↗
16. Influence of molecular weight and molecular weight distribution on mechanical properties of polymers10.1002/pen.760220402 ↗
17. Effect of crystallinity and related surface properties on gene expression of primary fibroblasts10.1039/D1RA07237D ↗
18. Microbial polyhydroxyalkanoates as medical implant biomaterials10.1080/21691401.2017.1371185 ↗
19. Design of therapeutic biomaterials to control inflammation10.1038/s41578-022-00426-z ↗
20. Human engineered heart muscles engraft and survive long term in a rodent myocardial infarction model10.1161/CIRCRESAHA.115.306985 ↗
21. Cardiac repair in Guinea pigs with human engineered heart tissue from induced pluripotent stem cells10.1126/scitranslmed.aaf8781 ↗
22. Large cardiac muscle patches engineered from human induced-pluripotent stem cell-derived cardiac cells improve recovery from myocardial infarction in swine10.1161/CIRCULATIONAHA.117.030785 ↗
23. In vivo grafting of large engineered heart tissue patches for cardiac repair10.1172/jci.insight.144068 ↗
24. Platelet endothelial cell adhesion Molecule‐1 mediates endothelial‐cardiomyocyte communication and regulates cardiac function
25. Endothelial-cardiomyocyte interactions in cardiac development and repair10.1146/annurev.physiol.68.040104.124629 ↗
26. Cardiomyocyte—endothelial cell interactions in cardiac remodeling and regeneration10.3389/fcvm.2018.00101 ↗
27. Generation and characterisation of scalable and stable human pluripotent stem cell-derived microvascular-like endothelial cells for cardiac applications10.1007/s10456-024-09929-5 ↗
28. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells10.1089/scd.2012.0490 ↗
29. Calcium handling in human embryonic stem cell-derived cardiomyocytes10.1634/stemcells.2007-0591 ↗
30. Transcriptome of human foetal heart compared with cardiomyocytes from pluripotent stem cells
31. Growth of engineered human myocardium with mechanical loading and vascular coculture10.1161/CIRCRESAHA.110.237206 ↗
32. The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells10.1016/j.biomaterials.2012.11.055 ↗
33. Micropattern platform promotes extracellular matrix remodeling by human PSC-Derived cardiac fibroblasts and enhances contractility of co-cultured cardiomyocytes10.14814/phy2.15045 ↗
34. Dalton
35. Poly(hydroxy alkanoate)s in medical applications10.15255/CABEQ.2014.2261 ↗
36. Characterization of polyhydroxyalkanoates produced at pilot scale from different organic wastes10.3389/fbioe.2021.628719 ↗
37. Melt electrospinning today: an opportune time for an emerging polymer process10.1016/j.progpolymsci.2016.01.001 ↗
38. Mouse models of myocardial infarction: comparing permanent ligation and ischaemia-reperfusion10.1242/dmm.046565 ↗
39. Poly-3-hydroxyoctanoate P(3HO), a medium chain length polyhydroxyalkanoate homopolymer from Pseudomonas mendocina10.1021/bm2001999 ↗
40. Bioresorbable and mechanically optimized nerve guidance conduit based on a naturally derived medium chain length polyhydroxyalkanoate and Poly(ε-Caprolactone) blend10.1021/acsbiomaterials.0c01476 ↗
41. In vivo tracking and 1 H/19 F magnetic resonance imaging of biodegradable polyhydroxyalkanoate/polycaprolactone blend scaffolds seeded with labeled cardiac stem cells10.1021/acsami.8b06096 ↗
42. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling10.1073/pnas.1200250109 ↗
43. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions10.1038/nprot.2012.150 ↗
44. Chemically defined generation of human cardiomyocytes10.1038/nmeth.2999 ↗
45. Chapter 1 - “stamp-off” to micropattern sparse, multicomponent features
46. In vivo imaging of immediate early gene expression dynamics segregates neuronal ensemble of memories of dual events10.1186/s13041-021-00798-3 ↗
47. Effect of aging on elastin functionality in human cerebral arteries10.1161/STROKEAHA.108.528091 ↗
48. High-resolution x-ray tomographic morphological characterisation of electrospun nanofibrous bundles for tendon and ligament regeneration and replacement10.1111/jmi.12720 ↗
49. Cardioprotection by very mild hypothermia in mice10.21037/cdt.2018.08.07 ↗
50. Myocardial viability imaging using manganese-enhanced MRI in the first hours after myocardial infarction10.1002/advs.202003987 ↗
51. T1 mapping detects pharmacological retardation of diffuse cardiac fibrosis in mouse pressure-overload hypertrophy10.1161/CIRCIMAGING.113.000993 ↗
52. Melt electrospinning writing of Poly-Hydroxymethylglycolide- co -ε-Caprolactone-Based scaffolds for cardiac tissue engineering10.1002/adhm.201700311 ↗
53. Force production in mechanically isolated cardiac myocytes from human ventricular muscle tissue10.1016/S0008-6363(98)00019-4 ↗
54. Functional maturation of human pluripotent stem cell derived cardiomyocytes in vitro - correlation between contraction force and electrophysiology10.1016/j.biomaterials.2015.01.067 ↗
55. A monocytic barrier to the humanization of immunodeficient mice10.2174/011574888X263597231001164351 ↗
56. Direct in vitro electrospinning with polymer melts10.1021/bm050777q ↗
57. Electroconductive melt electrowritten patches matching the mechanical anisotropy of human myocardium10.1002/adfm.201909880 ↗
58. Unlocking the print of poly(L-lactic acid) by melt electrowriting for medical application10.1016/j.eurpolymj.2023.112675 ↗
59. Melt electrowriting allows tailored microstructural and mechanical design of scaffolds to advance functional human myocardial tissue formation10.1002/adfm.201803151 ↗
60. Recombinant human collagen/chitosan-based soft hydrogels as biomaterials for soft tissue engineering10.1016/j.msec.2020.111846 ↗
61. Dimension-based design of melt electrowritten scaffolds10.1002/smll.201800232 ↗
62. Printomics: the high-throughput analysis of printing parameters applied to melt electrowriting10.1088/1758-5090/aafc41 ↗
63. The effects of voltage configurations on print accuracy in melt electrowriting10.1016/j.matlet.2022.133738 ↗
64. Dubey · 2017
65. Metabolic maturation media improve physiological function of human iPSC-Derived cardiomyocytes10.1016/j.celrep.2020.107925 ↗
66. Generation of left ventricle-like cardiomyocytes with improved structural, functional, and metabolic maturity from human pluripotent stem cells10.1016/j.crmeth.2023.100456 ↗
67. FDA no longer has to require animal testing for new drugs10.1126/science.adg6276 ↗
68. Microfibrous scaffolds guide stem cell lumenogenesis and brain organoid engineering10.1002/adma.202300305 ↗
69. Preservation of functional microvascular bed is vital for long-term survival of cardiac myocytes within large transmural post-myocardial infarction scar10.1369/0022155417741640 ↗
70. Human cancer growth and therapy in immunodeficient mouse models10.1101/pdb.top073585 ↗
71. Expandable human cardiovascular progenitors from stem cells for regenerating mouse heart after myocardial infarction10.1093/cvr/cvz181 ↗
72. Human ISL1(+) ventricular progenitors self-assemble into an in vivo functional heart patch and preserve cardiac function post infarction10.1016/j.ymthe.2018.02.012 ↗
73. Rapid transfer of endothelial cell sheet using a thermosensitive hydrogel and its effect on therapeutic angiogenesis10.1021/bm4011744 ↗
74. Exosomes secreted by endothelial cells derived from human induced pluripotent stem cells improve recovery from myocardial infarction in mice10.1186/s13287-023-03462-w ↗
75. Multi-modal imaging probe for assessing the efficiency of stem cell delivery to orthotopic breast tumours10.1039/D0NR03237A ↗
76. Microvessel co-transplantation improves poor remuscularization by hiPSC-cardiomyocytes in a complex disease model of myocardial infarction and type 2 diabetes10.1016/j.stemcr.2024.102394 ↗
77. MonoMax suture: a new long-term absorbable monofilament suture made from Poly-4-Hydroxybutyrate10.1155/2012/216137 ↗
78. Prospective evaluation of poly-4-hydroxybutyrate mesh in CDC class I/high-risk ventral and incisional hernia repair: 18-Month follow-up10.1007/s00464-017-5886-1 ↗
79. Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes10.1002/stem.1331 ↗
80. Human embryonic stem cell-derived cardiomyocytes regenerate non-human primate hearts10.1038/nature13233 ↗
81. 4D physiologically adaptable cardiac patch: a 4-month in vivo study for the treatment of myocardial infarction10.1126/sciadv.abb5067 ↗
82. Engineered heart muscle allografts for heart repair in primates and humans10.1038/s41586-024-08463-0 ↗
83. Cardiac regeneration using pluripotent stem cells—Progression to large animal models10.1016/j.scr.2014.06.005 ↗
84. Human engineered heart tissue patches remuscularize the injured heart in a dose-dependent manner10.1161/CIRCULATIONAHA.120.047904 ↗
85. Clinical outcome following late reperfusion with percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction
86. Why can primary angioplastics be ineffective despite the precocity of the intervention?10.1093/eurheartjsupp/suac102 ↗
87. Reperfusion injury in patients with acute myocardial infarction: JACC scientific statement10.1016/j.jacc.2024.02.056 ↗
88. Postsurgery echocardiography can predict the amount of ischemia-reperfusion injury and the resultant scar size10.1152/ajpheart.00672.2020 ↗